TY - JOUR
T1 - Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies
AU - Gadiparthi, Chiranjeevi
AU - Hans, Amneet
AU - Potts, Kyle
AU - Ismail, Mohammad K.
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/2
Y1 - 2018/2
N2 - Although muscle weakness is the pathognomonic feature of idiopathic inflammatory myopathies, systemic organ involvement is not uncommon. The gastrointestinal and hepatic manifestations are well known. Oropharyngeal dysphagia is the most common gastrointestinal symptom and can be severe. Gastric and small intestinal motility disorders, including chronic intestinal pseudo-obstruction, celiac disease, and inflammatory bowel disease have been described. Comprehensive cancer screening is warranted soon after the diagnosis of inflammatory myopathies due to high risk of occult malignancies. Elevated aminotransferases may suggest muscular injury rather than hepatic dysfunction. Knowledge regarding systemic involvement of inflammatory myopathies can assist in timely diagnosis of these complex disorders.
AB - Although muscle weakness is the pathognomonic feature of idiopathic inflammatory myopathies, systemic organ involvement is not uncommon. The gastrointestinal and hepatic manifestations are well known. Oropharyngeal dysphagia is the most common gastrointestinal symptom and can be severe. Gastric and small intestinal motility disorders, including chronic intestinal pseudo-obstruction, celiac disease, and inflammatory bowel disease have been described. Comprehensive cancer screening is warranted soon after the diagnosis of inflammatory myopathies due to high risk of occult malignancies. Elevated aminotransferases may suggest muscular injury rather than hepatic dysfunction. Knowledge regarding systemic involvement of inflammatory myopathies can assist in timely diagnosis of these complex disorders.
KW - Corticosteroids
KW - Creatine kinase
KW - Dermatomyositis
KW - Inclusion body myositis
KW - Oropharyngeal dysphagia
KW - Polymyositis
UR - http://www.scopus.com/inward/record.url?scp=85035019029&partnerID=8YFLogxK
U2 - 10.1016/j.rdc.2017.09.006
DO - 10.1016/j.rdc.2017.09.006
M3 - Review article
C2 - 29149920
AN - SCOPUS:85035019029
SN - 0889-857X
VL - 44
SP - 113
EP - 129
JO - Rheumatic Disease Clinics of North America
JF - Rheumatic Disease Clinics of North America
IS - 1
ER -